AstraZeneca teams up with Imperial offshoot VaxEquity on an RNA 3.0 effort

Paul Schloesser

Associate Editor

Last year, Imperial College London professor Robin Shattock was given close to $50 million by the UK government to make an RNA-based Covid-19 vaccine. While …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AstraZeneca teams up with Imperial offshoot VaxEquity on an RNA 3.0 effort

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline

New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug

We’re about to find out which RFK Jr. will show up at HHS

Amgen announces hold on Phase 1 obesity candidate, pipeline cuts

Astellas shakes up management despite impressive nine-month earnings

Illumina added to China's blacklist following Biosecure Act, tariffs

As­traZeneca teams up with Im­pe­r­i­al off­shoot Vax­E­quity on an RNA 3.0 ef­fort

Associate Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

AstraZeneca teams up with Imperial offshoot VaxEquity on an RNA 3.0 effort